L-Dopa vs. R-Dopa: Why Only L-Dopa Treats Parkinson's & Dopa-Responsive Dystonia
L-Dopa (levodopa) is the biologically active enantiomer; R-dopa is inactive at human aromatic L-amino acid decarboxylase (AADC).
- Parkinson's disease: L-Dopa crosses BBB → converted to dopamine in striatum → replenishes nigrostriatal deficit. Gold standard since 1960s. Combined with carbidopa (peripheral decarboxylase inhibitor) to reduce nausea/hypotension.
- Dopa-responsive dystonia (DRD): Autosomal dominant GCH1 mutation → BH₄ deficiency → impaired dopamine synthesis. L-Dopa dramatically restores motor function.
- RLS/PLMD: Sometimes used off-label for dopamine-deficient phenotypes.
Long-term issues: motor fluctuations, dyskinesias, psychosis. Requires specialist titration.
Diseases - Related Articles
- Hypersensitivity Pneumonitis: Causes, Symptoms & Risk Factors
- Understanding Hormone Refractory Prostate Cancer: Prognosis & Treatment
- Activated Charcoal: Can It Help with Staph Infections?
- Sickle Cell Disease: Understanding Survival Rates and Advances
- Cushing's Syndrome: Causes, Symptoms & Differential Diagnosis
- Disease Prevention: Hygiene, Lifestyle, Vaccines & Travel Safety
- Canker Sores: Causes, Symptoms & Treatment Options